Status:
UNKNOWN
Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients
Lead Sponsor:
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
Conditions:
COVID-19
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The study is devoted to the comparative analysis of the data received in patients with COVID-19 lung pathology using the method of probe-based confocal laser endomicroscopy of distal airways and two r...
Eligibility Criteria
Inclusion
- Patient Informed Consent;
- the diagnosis of COVID-19 or one of the following lung diseases: chronic obstructive pulmonary disease, pneumonia, solitary nodule, pulmonary sarcoidosis, idiopathic interstitial pneumonia, hypersensitivity pneumonitis, pulmonary vasculitis, pulmonary eosinophilia, hemochromatosis, histiocytosis X, pulmonary lymphangioleiomyomatosis; alveolar proteinosis, other rare lung disease
- high resolution computed tomography scans performed not later than one month before pCLE (for non-COVID-19);
- planned or performed histology (for non-COVID-19)
- Severe respiratory failure,
Exclusion
- pregnancy or breast feeding,
- lung bleeding,
- any acute or chronic disease that may be a contraindication to bronchoscopy,
- any diseases of hematopoietic system,
- taking part in other clinical trials
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04451889
Start Date
August 1 2020
End Date
September 1 2021
Last Update
July 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal Research Clinical Center FMBA Russia
Moscow, Russia, 115682